• Disease areas
  • Science & technology
  • Partnering
  • Sustainable business
  • Careers
  • About us
  • Our products
  • Investors
  • News & media
  • Healthcare professionals
  • Contact us

Investors

Investor highlights Financial results, events and calendar Annual General Meeting 2026 Annual Report 2025 ESG Share information Investor Portal Bond information News & Company Announcement archive Contact Investor Relations

NOVO NORDISK HQ

Novo Nordisk A/S
Novo Alle 1
2880 Bagsværd
Denmark
+45-4444-8888
CVR-no. 24256790

 

Our medicines are for the approved indication for which they are authorised in the local country or region. For more information, please visit our product page

Helpful links

  • Contact us about a product issue or side effect
  • Supplier help
  • Product list
  • Contact us
  • Our Purpose - Code of conduct
  • ESG reporting
  • Novo Nordisk Foundation

Follow us

  • Social media community guidelines
  • LinkedIn
  • YouTube
  • Facebook
  • X (Twitter)
  • Instagram
  • TikTok

Find your local office

Select location
© 2026 Novo Nordisk A/S
Data Privacy
Cookie policy
Cookie settings

change